St. Francis Cancer Center | St. Francis Cancer Center | IMGN 529-0302
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1569
clinical-trial-template-default,single,single-clinical-trial,postid-1569,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

IMGN 529-0302

A Phase 2 Study to Evaluate the Efficacy and Tolerability of IMGN529 in Combination with Rituximab in Patients with Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma and Other Forms of Non-Hodgkin’s Lymphoma. Read More>

« Available Clinical Trials